Shandong Pharmaceutical (China) Today
| 600529 Stock | 24.21 0.29 1.18% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Shandong Pharmaceutical is trading at 24.21 as of the 29th of November 2024, a 1.18 percent decrease since the beginning of the trading day. The stock's open price was 24.5. Shandong Pharmaceutical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Shandong Pharmaceutical Glass are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of June 2023 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of June 2002 | Category Consumer Cyclical | Classification Health Care |
Shandong Pharmaceutical is entity of China. It is traded as Stock on SHG exchange. The company has 663.61 M outstanding shares. More on Shandong Pharmaceutical Glass
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shandong Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shandong Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shandong Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Consumer Cyclical, Health Care, Health Care Equipment & Supplies, Health Care Equipment & Services, Consumer Cyclical (View all Sectors) | ||||
Shandong Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shandong Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShandong Pharmaceutical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shandong Pharmaceutical's financial leverage. It provides some insight into what part of Shandong Pharmaceutical's total assets is financed by creditors.
| |||||
Shandong Pharmaceutical Glass (600529) is traded on Shanghai Stock Exchange in China and employs 6,473 people. Shandong Pharmaceutical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shandong Pharmaceutical's market, we take the total number of its shares issued and multiply it by Shandong Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shandong Pharmaceutical operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 663.61 M outstanding shares.
Shandong Pharmaceutical generates positive cash flow from operations, but has no cash available
Check Shandong Pharmaceutical Probability Of Bankruptcy
Ownership AllocationShandong Pharmaceutical shows a total of 663.61 Million outstanding shares. Shandong Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shandong Ownership Details
Shandong Pharmaceutical Risk Profiles
Although Shandong Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Shandong Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.59 | |||
| Semi Deviation | 2.11 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.49 |
Shandong Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shandong Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Shandong Pharmaceutical Corporate Management
Elected by the shareholders, the Shandong Pharmaceutical's board of directors comprises two types of representatives: Shandong Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Pharmaceutical's management team and ensure that shareholders' interests are well served. Shandong Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yizhao Song | Chief Officer | Profile | |
| Wansheng He | Deputy Manager | Profile | |
| Bin Du | Deputy Manager | Profile | |
| Yucai Su | Deputy Manager | Profile |
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.